- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Profusa, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| Fr | Profusa, Inc. - S-1, General form for registration of securities | 2 | SEC Filings | ||
| PROFUSA Aktie jetzt für 0€ handeln | |||||
| Fr | Profusa, Mayo Clinic collab on oxygen monitoring tech | 4 | MassDevice | ||
| Do | Profusa, Inc.: Profusa and Mayo Clinic collaborate to Advance High-Impact Clinical Applications of Oxygen Monitoring Technologies | 3 | GlobeNewswire (USA) | ||
| 05.02. | Profusa, Inc.: Profusa Announces 1-for-75 Reverse Stock Split | 165 | GlobeNewswire (Europe) | BERKELEY, California, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. ("Profusa" or the "Company") (Nasdaq: PFSA), a commercial stage digital health company pioneering a next-generation technology platform... ► Artikel lesen | |
| 02.02. | Profusa, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 29.01. | Profusa, Inc.: Profusa Presents Positive US-Study Clinical Results at Leipzig Interventional Course (LINC) 2026 | 3 | GlobeNewswire (USA) | ||
| 16.01. | Profusa Stock Spikes As Lumee System Targets Research Market | 3 | Benzinga.com | ||
| 16.01. | Profusa launches tissue oxygen monitoring system for research market | 3 | Investing.com | ||
| 16.01. | Profusa, Inc.: Profusa Launches Lumee Tissue Oxygen Healthcare Research Offerings, Initiating First Commercial Revenue | 2 | GlobeNewswire (USA) | ||
| 08.01. | Profusa, Inc.: Profusa Adds Leading Greek Vascular Surgeon to Customer Base | 1 | GlobeNewswire (USA) | ||
| 31.12.25 | Profusa expands European footprint with French distributor partnership | 1 | Investing.com | ||
| 31.12.25 | Profusa expandiert in Europa: Vertriebspartnerschaft für Frankreich geschlossen | 2 | Investing.com Deutsch | ||
| 31.12.25 | Profusa, Inc.: Profusa Bolsters European Commercial Network with New French Distributor, MedSell | 1 | GlobeNewswire (USA) | ||
| 30.12.25 | Profusa Shares Rise 80% On Debt Restructuring News | 1 | RTTNews | ||
| 30.12.25 | Profusa ermöglicht Verkauf von Schuldverschreibungen im Wert von 5 Mio. US-Dollar durch Vertragsanpassung | 4 | Investing.com Deutsch | ||
| 30.12.25 | Profusa restructures senior secured convertible notes | 3 | Seeking Alpha | ||
| 30.12.25 | Profusa restrukturiert konvertierbare Anleihe für mehr Flexibilität und weniger Aktienverwässerung | 1 | Investing.com Deutsch | ||
| 30.12.25 | Profusa restructures convertible note to reduce dilution, increase flexibility | 4 | Investing.com | ||
| 30.12.25 | Profusa, Inc.: Profusa Restructures Senior Secured Convertible Notes, Only Convertible Above $0.35 | 2 | GlobeNewswire (USA) |
1 2 3 4 Weiter >>
61 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| HEARTFLOW | 20,610 | -8,36 % | Heartflow, Inc.: Heartflow to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026 | ||
| PROGYNY | 20,690 | -1,38 % | Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2025 Results Report | ||
| BRIGHTSPRING HEALTH SERVICES | 38,830 | +2,75 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 20,180 | +0,65 % | Alignment Healthcare Reports 31% Year-Over-Year Membership Growth to 275,300 as of Jan. 1, 2026 | Guides year-end 2026 health plan membership range of 290,000 to 296,000. Announces its expectation that consensus adjusted EBITDA of approximately $145 million in 2026 will be within its full-year... ► Artikel lesen | |
| ADAPTHEALTH | 10,200 | +1,09 % | AdaptHealth: Strategische Expansion und Technologie-Investitionen als Wachstumstreiber | ||
| SIEMENS HEALTHINEERS | 40,630 | +0,67 % | BERNSTEIN RESEARCH stuft Siemens Healthineers auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat das Kursziel für Siemens Healthineers von 52,90 auf 52,15 Euro gesenkt, aber die Einstufung auf "Outperform" belassen. Der Medizintechnikkonzern... ► Artikel lesen | |
| GENEDX | 90,21 | -0,51 % | Forecasting The Future: 4 Analyst Projections For GeneDx Holdings | ||
| BETA BIONICS | 13,940 | +2,88 % | UBS initiates coverage on Beta Bionics stock with Buy rating | ||
| PROCEPT BIOROBOTICS | 27,790 | -1,07 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 7,035 | +1,66 % | LifeStance Health Group, Inc.: LifeStance Reports Third Quarter 2025 Results | SCOTTSDALE, Ariz., Nov. 06, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| RXSIGHT | 8,040 | +3,08 % | RxSight, Inc. (RXST) Initiated at Market Perform as Firm Seeks Sales Reacceleration | ||
| PRIVIA HEALTH GROUP | 22,400 | +4,19 % | Privia Health Group, Inc.: Privia Health Reports Third Quarter 2025 Financial Results | Very Strong Third Quarter and Year-to-Date Performance Across the BusinessNet Income +94.1% and Adjusted EBITDA +61.6% compared to 3Q'24Implemented Providers +13.1% and Practice Collections +27.1%... ► Artikel lesen | |
| PACS GROUP | 37,815 | -2,79 % | Morning Market Movers: Mobile-health Network Solutions, PACS Group, Brera Holdings, Cerence See Big Swings | SANTA CLARA (dpa-AFX) - At 7:55 a.m. ET on Thursday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| CLEARPOINT NEURO | 13,560 | +3,99 % | ClearPoint Neuro, Inc. - S-8, Securities to be offered to employees in employee benefit plans | ||
| TALKSPACE | 3,770 | -0,26 % | Canaccord Genuity reiterates Buy rating on TalkSpace stock with $6 target |
PROFUSA INC gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von -0,970 (-32,12 %) liegt der Kurs bei 2,050 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu PROFUSA INC finden Sie auf Wallstreet Online.